What is Artificial Labs?
Artificial Labs operates at the intersection of fintech and insurance, providing a sophisticated platform designed to modernize placement and underwriting processes. By streamlining complex workflows and facilitating seamless connectivity between market participants, the company addresses the long-standing inefficiencies inherent in specialty coverage. Its technology-first approach empowers teams to move away from manual, fragmented processes toward data-driven risk decisions, fostering stronger client relationships and operational excellence. As the industry undergoes a digital transformation, Artificial Labs serves as a vital infrastructure provider, enabling insurers to scale their operations while maintaining the agility required in a competitive, high-stakes environment.
How much funding has Artificial Labs raised?
Artificial Labs has raised a total of $55.3M across 3 funding rounds:
Angel/Seed
$5.3M
Series A
$5.1M
Series B
$45M
Angel/Seed (2019): $5.3M with participation from Force Over Mass
Series A (2024): $5.1M led by Augmentum Fintech, Force Over Mass, and Ms&ad Ventures
Series B (2026): $45M supported by Augmentum Fintech, 6 Degrees Capital, Move Capital, CommerzVentures, TrueSight Ventures, and Force Over Mass Capital
Key Investors in Artificial Labs
Augmentum Fintech
Augmentum is a publicly listed investment firm specializing in high-growth fintech businesses across the UK and Europe, providing patient capital to support long-term scaling.
Force Over Mass
A venture capital firm focused on backing contrarian founders and early-stage technology businesses, emphasizing superior returns through dynamic asset allocation.
Ms&ad Ventures
The corporate venture arm of MS&AD Insurance Group Holdings, dedicated to early-stage investments in insurtech and fintech startups to drive global innovation.
What's next for Artificial Labs?
With the successful closure of its Series B round, Artificial Labs is poised to enter a phase of aggressive market expansion and product innovation. The strategic focus will likely center on deepening the platform's analytical capabilities and expanding its footprint within the international specialty insurance market. By utilizing the recent capital, the company is expected to enhance its machine learning and data analytics features, further automating the underwriting lifecycle. As it continues to scale, Artificial Labs will likely prioritize the integration of its solutions into broader enterprise ecosystems, solidifying its position as a cornerstone of the modern insurance value chain. The ongoing support from its diverse investor base provides not only the necessary financial runway but also the strategic guidance required to navigate the complexities of global insurance markets.
See full Artificial Labs company page
